Asher, N.; Israeli-Weller, N.; Shapira-Frommer, R.; Ben-Betzalel, G.; Schachter, J.; Meirson, T.; Markel, G.
Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience. Cancers 2021, 13, 3074.
https://doi.org/10.3390/cancers13123074
AMA Style
Asher N, Israeli-Weller N, Shapira-Frommer R, Ben-Betzalel G, Schachter J, Meirson T, Markel G.
Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience. Cancers. 2021; 13(12):3074.
https://doi.org/10.3390/cancers13123074
Chicago/Turabian Style
Asher, Nethanel, Noa Israeli-Weller, Ronnie Shapira-Frommer, Guy Ben-Betzalel, Jacob Schachter, Tomer Meirson, and Gal Markel.
2021. "Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience" Cancers 13, no. 12: 3074.
https://doi.org/10.3390/cancers13123074
APA Style
Asher, N., Israeli-Weller, N., Shapira-Frommer, R., Ben-Betzalel, G., Schachter, J., Meirson, T., & Markel, G.
(2021). Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience. Cancers, 13(12), 3074.
https://doi.org/10.3390/cancers13123074